<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.9" extension="2015-08-01"/>
  <id root="cd0b64ba-ed9e-4d86-84eb-307236e48bbe"/>
  <code code="11506-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Progress note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Higuchi Ichiyō — True-date frame: synthetic events are moved into the patient&apos;s historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.</title>
  <effectiveTime value="18960417120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="a40c6d87-50f0-4efc-be62-69e2524e6dec"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="7c22f40e-9344-493f-b538-cbb24b9962db" extension="HR-NI029-SYN-TD"/>
      <id root="2.16.840.1.113883.4.1" extension="000-29-5108"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><family>Higuchi</family><given>Ichiyō</given></name>
        <administrativeGenderCode code="F" codeSystem="2.16.840.1.113883.5.1" displayName="Female"/>
        <birthTime value="18720502"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="18960417120000-0500"/>
    <assignedAuthor><id root="b58b6331-62d8-4d12-8329-5a5de9e074a0"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Aiko</given><family>Lindgren-Tanaka</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="18960417120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="b58b6331-62d8-4d12-8329-5a5de9e074a0"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Aiko</given><family>Lindgren-Tanaka</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <documentationOf>
    <serviceEvent classCode="PCPR"><templateId root="2.16.840.1.113883.10.20.21.3.1"/><effectiveTime><low value="18960417"/><high value="18960417"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="b58b6331-62d8-4d12-8329-5a5de9e074a0"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Aiko</given><family>Lindgren-Tanaka</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="a0529542-b6c8-4710-829f-ddafb6dd2666"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>Results visit: pulmonary tuberculosis confirmed; infectious diseases consultation and the start of the standard six-month regimen</originalText></code>
      <effectiveTime><low value="18960417"/><high value="18960417"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="b58b6331-62d8-4d12-8329-5a5de9e074a0"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Aiko</given><family>Lindgren-Tanaka</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.1.13.2.1"/>
    <code code="10154-3" codeSystem="2.16.840.1.113883.6.1" displayName="Chief complaint Narrative - Reported"/>
    <title>Chief Complaint</title>
    <text><paragraph>Results visit: sputum tests, with infectious diseases consultation the same day. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Ms. Higuchi returns three days after her first visit for her results and is seen by Dr. Abernathy-Okoye of infectious diseases today. She brought the second and third sputum specimens, the last collected on waking this morning. Since her first visit she has stayed home, slept in her own room with the window open, and worn a surgical mask in the shared rooms; no one has visited. The cough is unchanged, with a little white sputum and no blood, and she still has evening fevers and night sweats. She is eating a little more since the dietitian&apos;s first call. She has not written since her first visit. She is worried about the people she lives with and about the cost of treatment. [S]</paragraph><table><thead><tr><th>Element</th><th>Detail</th></tr></thead><tbody><tr><td>Symptoms</td><td>Cough, evening fevers and night sweats unchanged; no hemoptysis</td></tr><tr><td>Precautions</td><td>At home with a mask in shared rooms; no visitors</td></tr><tr><td>Testing</td><td>Three sputum specimens complete; blood results back</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.18"/>
    <code code="10187-3" codeSystem="2.16.840.1.113883.6.1" displayName="Review of systems Narrative - Reported"/>
    <title>Review of Systems</title>
    <text><table><thead><tr><th>System</th><th>Result</th><th>Finding</th></tr></thead><tbody><tr><td>Respiratory</td><td>Positive</td><td>Cough with a little white sputum; no blood; breathless on the stairs</td></tr><tr><td>Constitutional</td><td>Positive</td><td>Evening fevers, night sweats and tiredness</td></tr><tr><td>Eyes</td><td>Negative</td><td>No blurred vision</td></tr><tr><td>Psychiatric</td><td>Positive</td><td>Worried about her household and costs; no thoughts of self-harm</td></tr></tbody></table><paragraph>4 systems reviewed. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Isoniazid 100 mg tablets, two tablets (200 mg) daily</td><td>200 mg once daily, observed by video each day through the public health center&apos;s directly observed treatment program, for 26 weeks</td><td>Oral route</td><td>1896-04-17 to 1896-10-15</td><td>completed</td><td>S</td></tr><tr ID="medication-2"><td>Rifampin (rifampicin) 150 mg capsules, three capsules (450 mg) daily</td><td>450 mg once daily on an empty stomach, observed by video each day through the public health center&apos;s directly observed treatment program, for 26 weeks</td><td>Oral route</td><td>1896-04-17 to 1896-10-15</td><td>completed</td><td>S</td></tr><tr ID="medication-3"><td>Pyrazinamide 500 mg tablets, two tablets (1000 mg) daily</td><td>1000 mg once daily, observed by video each day through the public health center&apos;s directly observed treatment program, for the eight-week intensive phase</td><td>Oral route</td><td>1896-04-17 to 1896-06-11</td><td>completed</td><td>S</td></tr><tr ID="medication-4"><td>Ethambutol 100 mg tablets, six tablets (600 mg) daily</td><td>600 mg once daily, observed by video each day through the public health center&apos;s directly observed treatment program, until susceptibility results return</td><td>Oral route</td><td>1896-04-17 to 1896-05-22</td><td>stopped</td><td>S</td></tr><tr ID="medication-5"><td>Vitamin B6 (pyridoxine) 50 mg tablet, one tablet daily</td><td>50 mg once daily with isoniazid</td><td>Oral route</td><td>1896-04-17 to 1896-10-15</td><td>completed</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="7eb3276a-de12-431d-a4d9-e2bd3145700e"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="18960417"/><high value="18961015"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="200" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="311166" codeSystem="2.16.840.1.113883.6.88" displayName="isoniazid 100 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="ccdef7a3-c3df-42d2-86a6-9fad08dfac47"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="0bf7d647-e98b-477b-9c77-fedbf503c700"/>
      <text><reference value="#medication-2"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="18960417"/><high value="18961015"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="450" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="198201" codeSystem="2.16.840.1.113883.6.88" displayName="rifampin 150 MG Oral Capsule"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="56b21235-29ce-4431-8141-186844a40a96"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="0d58f885-17ab-46de-b503-c91259f682bd"/>
      <text><reference value="#medication-3"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="18960417"/><high value="18960611"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1000" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="198181" codeSystem="2.16.840.1.113883.6.88" displayName="pyrazinamide 500 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="7f70c407-ccd3-42d8-b9ec-51ef6399a56e"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="6558ebd9-69d9-4368-b317-536ef78b8f3c"/>
      <text><reference value="#medication-4"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="18960417"/><high value="18960522"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="600" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="995599" codeSystem="2.16.840.1.113883.6.88" displayName="ethambutol hydrochloride 100 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="2ab12a07-fcc9-4028-a727-e240b0333ae5"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="fed5d39a-47ce-41ea-aebf-d1535c103655"/>
      <text><reference value="#medication-5"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="18960417"/><high value="18961015"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="50" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="639566" codeSystem="2.16.840.1.113883.6.88" displayName="vitamin B6 50 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="5202f024-3416-4ff6-9a8d-b6b696c0742b"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="be269c3d-751f-4312-91b1-01e458685ae6"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="18960414"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="984ff2b6-e308-46d6-8fa2-c6db82d2c467"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.4" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.4.1" extension="2015-08-01"/>
    <code code="8716-3" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs"/>
    <title>Vital Signs</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="vital-2-1"><td>1896-04-17</td><td>Body height</td><td>148</td><td>cm</td><td>S</td></tr>
  <tr ID="vital-2-2"><td>1896-04-17</td><td>Body weight</td><td>38.4</td><td>kg</td><td>S</td></tr>
  <tr ID="vital-2-3"><td>1896-04-17</td><td>Body mass index (BMI) [Ratio]</td><td>17.5</td><td>kg/m2</td><td>S</td></tr>
  <tr ID="vital-2-4"><td>1896-04-17</td><td>Systolic blood pressure</td><td>96</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-2-5"><td>1896-04-17</td><td>Diastolic blood pressure</td><td>60</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-2-6"><td>1896-04-17</td><td>Heart rate</td><td>100</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-2-7"><td>1896-04-17</td><td>Respiratory rate</td><td>20</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-2-8"><td>1896-04-17</td><td>Body temperature</td><td>37.6</td><td>Cel</td><td>S</td></tr>
  <tr ID="vital-2-9"><td>1896-04-17</td><td>Oxygen saturation in Arterial blood by Pulse oximetry</td><td>96</td><td>%</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.26" extension="2015-08-01"/>
      <id root="3923f433-69ef-45b7-9a82-bebee5b9be9d"/>
      <code code="74728-7" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs, weight, height, head circumference, oximetry, BMI, and BSA panel - HL7.FHIR.R4"/>
      <statusCode code="completed"/><effectiveTime value="18960417"/>
      <component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="60eb6ccd-010c-47a0-8986-85f05ed92890"/><code code="8302-2" codeSystem="2.16.840.1.113883.6.1" displayName="Body height"/><text><reference value="#vital-2-1"/></text><statusCode code="completed"/><effectiveTime value="18960417"/><value xsi:type="PQ" value="148" unit="cm"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="72329be9-a5cb-4b06-b23b-915885deeb29"/><code code="29463-7" codeSystem="2.16.840.1.113883.6.1" displayName="Body weight"/><text><reference value="#vital-2-2"/></text><statusCode code="completed"/><effectiveTime value="18960417"/><value xsi:type="PQ" value="38.4" unit="kg"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="c5f92a49-0fc4-4b18-bfca-df44823d3406"/><code code="39156-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body mass index (BMI) [Ratio]"/><text><reference value="#vital-2-3"/></text><statusCode code="completed"/><effectiveTime value="18960417"/><value xsi:type="PQ" value="17.5" unit="kg/m2"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="bc9dbba8-f614-4eec-a8e5-de7610c826da"/><code code="8480-6" codeSystem="2.16.840.1.113883.6.1" displayName="Systolic blood pressure"/><text><reference value="#vital-2-4"/></text><statusCode code="completed"/><effectiveTime value="18960417"/><value xsi:type="PQ" value="96" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="ecf3cad5-30b0-4607-8ead-55de9cd81a6c"/><code code="8462-4" codeSystem="2.16.840.1.113883.6.1" displayName="Diastolic blood pressure"/><text><reference value="#vital-2-5"/></text><statusCode code="completed"/><effectiveTime value="18960417"/><value xsi:type="PQ" value="60" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="934fcca7-5de7-42dc-aa60-ee38bfe2d82f"/><code code="8867-4" codeSystem="2.16.840.1.113883.6.1" displayName="Heart rate"/><text><reference value="#vital-2-6"/></text><statusCode code="completed"/><effectiveTime value="18960417"/><value xsi:type="PQ" value="100" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="07acf16c-456e-402a-8e92-d5f54ee2ffcd"/><code code="9279-1" codeSystem="2.16.840.1.113883.6.1" displayName="Respiratory rate"/><text><reference value="#vital-2-7"/></text><statusCode code="completed"/><effectiveTime value="18960417"/><value xsi:type="PQ" value="20" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="8f3ccaae-2e66-4d04-a8e1-dce25e7992f6"/><code code="8310-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body temperature"/><text><reference value="#vital-2-8"/></text><statusCode code="completed"/><effectiveTime value="18960417"/><value xsi:type="PQ" value="37.6" unit="Cel"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="820789c6-1f57-416f-9967-c991cde9580a"/><code code="59408-5" codeSystem="2.16.840.1.113883.6.1" displayName="Oxygen saturation in Arterial blood by Pulse oximetry"/><text><reference value="#vital-2-9"/></text><statusCode code="completed"/><effectiveTime value="18960417"/><value xsi:type="PQ" value="96" unit="%"/></observation></component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section nullFlavor="NI">
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1"/>
    <title>Results</title>
    <text><paragraph>No results recorded at this visit.</paragraph></text>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 1896-04-17; see the Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Thin and tired; weight 38.4 kg; temperature 37.6 °C, pulse 100; seen in an airborne infection isolation room with staff wearing respirators</td></tr><tr><td>Respiratory</td><td>Fine crackles over the right upper zone; no wheeze</td></tr><tr><td>Eyes</td><td>No icterus</td></tr><tr><td>Abdomen</td><td>Soft and non-tender; liver not enlarged</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Cough for about seven weeks with evening fevers, night sweats, poor appetite and weight loss of about 4 kg (about 10 percent) in a woman of 23; chest X-ray with patchy right upper lobe opacities and no cavity; suspected pulmonary tuberculosis; airborne precautions and three sputum specimens for acid-fast smear, nucleic acid amplification and culture</td><td>resolved</td><td>confirmed</td>
    <td>R05.3</td><td>S — Synthetic presenting problem at intake, superseded by the diagnosis at the second visit; its timing echoes her documented decline from early 1896 (D).</td>
  </tr>
  <tr ID="problem-2">
    <td>Pulmonary tuberculosis of the right upper lobe, sputum smear-negative, confirmed by Xpert MTB/RIF Ultra (Mycobacterium tuberculosis detected, low; rifampin resistance not detected)</td><td>active</td><td>confirmed</td>
    <td>A15.0</td><td>S — Synthetic modern coding of her documented tuberculosis; all bacteriology and imaging are synthetic.</td>
  </tr>
  <tr ID="problem-3">
    <td>Moderate protein-calorie malnutrition: BMI 17.6, about 10 percent weight loss in two months, and albumin 3.3 g/dL</td><td>active</td><td>confirmed</td>
    <td>E44.0</td><td>S — Synthetic nutrition diagnosis at intake, anchored to her documented poverty.</td>
  </tr>
  <tr ID="problem-4">
    <td>Low and irregular income from writing, with a household to support; costs of care are a barrier</td><td>active</td><td>confirmed</td>
    <td>Z59.6</td><td>S — Synthetic social need anchored to her documented poverty and household responsibilities.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="b9361495-8b90-4c80-838e-76c214dd2337"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="18960414"/><high value="18960417"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="73cd24d0-95f6-4102-b5d0-a9b0ab8d2cba"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="18960414"/><high value="18960417"/></effectiveTime>
          <value xsi:type="CD" code="R05.3" codeSystem="2.16.840.1.113883.6.90" displayName="Chronic cough"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="782d0e79-416e-4d80-af17-21eaeee6a892"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="18960417"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="5fd46535-ad33-4118-a1cf-1b610794c031"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="18960417"/></effectiveTime>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="c4b57cae-ab27-4937-845f-7438131c077e"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="18960414"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="db7103d1-24e3-42e8-b572-a63b7d2158cc"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="18960414"/></effectiveTime>
          <value xsi:type="CD" code="E44.0" codeSystem="2.16.840.1.113883.6.90" displayName="Moderate protein-calorie malnutrition"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="487e188b-4fbe-4add-b0aa-df4dec75a24f"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="18960414"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="be39c0a5-f14b-4ba7-954b-b990da587345"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-4"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="18960414"/></effectiveTime>
          <value xsi:type="CD" code="Z59.6" codeSystem="2.16.840.1.113883.6.90" displayName="Low income"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.9" extension="2014-06-09"/>
    <code code="51847-2" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation + Plan note"/>
    <title>Assessment and Plan</title>
    <text><list listType="ordered"><item><content styleCode="Bold">Pulmonary tuberculosis, smear-negative, Xpert-confirmed (A15.0)</content>. All three sputum smears are negative for acid-fast bacilli, but Xpert MTB/RIF Ultra on the first specimen detected Mycobacterium tuberculosis at a low level with no rifampin resistance, which with her symptoms and the right upper lobe opacities confirms pulmonary tuberculosis. Cultures and susceptibility testing are pending. HIV, hepatitis B surface antigen, hepatitis C antibody and the pregnancy test are negative. Liver and kidney tests are normal, hemoglobin A1c 5.1%, and visual acuity 85 letters in each eye with normal color vision. At 38.5 kg she is below the 40 kg needed for the four-month rifapentine-moxifloxacin regimen, so the standard six-month regimen is used. Dr. Abernathy-Okoye agrees the regimen, doses and monitoring. [S]<list><item>Isoniazid 200 mg, rifampin 450 mg, pyrazinamide 1000 mg and ethambutol 600 mg daily, with pyridoxine 50 mg, from today; first dose taken in the clinic.</item><item>Daily video-observed therapy with the public health center from tomorrow.</item><item>Notification to the public health center today.</item><item>Liver tests and vision at two weeks; call the same day for nausea, vomiting, abdominal pain, yellow eyes, dark urine or any change in vision.</item><item>Expect orange urine and tears.</item></list></item><item><content styleCode="Bold">Moderate protein-calorie malnutrition (E44.0)</content>. Weight 38.4 kg; eating slightly more. [S]<list><item>Second dietitian visit next week; supplement drinks twice daily.</item></list></item><item><content styleCode="Bold">Low income (Z59.6)</content>. Treatment costs are her main fear. Outpatient tuberculosis drugs, X-rays and sputum tests qualify for public funding of 95 percent under the Infectious Diseases Control Law. [S]<list><item>Medical social worker to complete the public funding application with her today.</item></list></item></list><paragraph>Protocol monitoring: items the monitoring protocol calls for at this visit. [S]</paragraph><table><thead><tr><th>Domain</th><th>Measure</th><th>Interval</th><th>Status</th><th>Detail</th></tr></thead><tbody><tr><td>Laboratory</td><td>Sputum smear and culture</td><td>At diagnosis, at two weeks, and at the end of the intensive phase (two months)</td><td>Completed today</td><td>Three specimens, one on waking: smears negative for acid-fast bacilli; liquid and solid cultures pending</td></tr><tr><td>Laboratory</td><td>Xpert MTB/RIF Ultra (nucleic acid amplification with rifampin resistance)</td><td>At diagnosis</td><td>Completed today</td><td>Mycobacterium tuberculosis detected, low; rifampin resistance not detected</td></tr><tr><td>Laboratory</td><td>Drug susceptibility testing of the first isolate</td><td>Once, on the first positive culture</td><td>Ordered</td><td>Phenotypic susceptibility to first-line drugs to be set up on the first positive culture</td></tr><tr><td>Laboratory</td><td>HIV test</td><td>At diagnosis</td><td>Up to date</td><td>HIV-1/2 antigen and antibody test negative</td></tr><tr><td>Laboratory</td><td>Hepatitis B and C serology</td><td>At diagnosis</td><td>Up to date</td><td>Hepatitis B surface antigen, surface antibody and core antibody negative (not immune); hepatitis C antibody negative</td></tr><tr><td>Laboratory</td><td>Pregnancy test</td><td>Before starting treatment in a woman who could be pregnant</td><td>Up to date</td><td>Negative at intake</td></tr><tr><td>Laboratory</td><td>Diabetes screen (hemoglobin A1c)</td><td>At diagnosis</td><td>Up to date</td><td>5.1% at intake</td></tr><tr><td>Laboratory</td><td>Liver tests (ALT, AST, bilirubin)</td><td>Baseline; at two weeks and monthly in the intensive phase because of low weight and albumin; then for symptoms</td><td>Up to date</td><td>Normal at intake (ALT 12, AST 19 U/L, bilirubin 0.4 mg/dL); albumin 3.3 g/dL</td></tr><tr><td>Imaging</td><td>Visual acuity and color vision</td><td>Baseline and monthly while on ethambutol</td><td>Up to date</td><td>85 letters in each eye with normal color vision at intake, before ethambutol</td></tr><tr><td>Imaging</td><td>Chest X-ray</td><td>At diagnosis and at the end of treatment as a new baseline</td><td>Up to date</td><td>Right upper lobe opacities without a cavity at intake</td></tr><tr><td>Medication safety</td><td>Regimen choice and weight-based doses</td><td>At the start of treatment</td><td>Completed today</td><td>Standard six-month regimen; not eligible for the four-month rifapentine-moxifloxacin regimen at 38.5 kg. Isoniazid 5, rifampin 12, pyrazinamide 26 and ethambutol 16 mg/kg</td></tr><tr><td>Medication safety</td><td>Doses observed and missed (video-observed therapy)</td><td>Every visit</td><td>Completed today</td><td>First dose observed in the clinic; video-observed therapy from tomorrow</td></tr><tr><td>Medication safety</td><td>Rifampin drug-interaction review, including hormonal contraception</td><td>With every new medicine</td><td>Completed today</td><td>No other medicines; told that rifampin weakens hormonal contraceptives and interacts with many drugs</td></tr><tr><td>Self-management</td><td>Home precautions and the criteria for release</td><td>Until two weeks of treatment with clinical improvement, for smear-negative disease</td><td>Completed today</td><td>Precautions at home continue; smear-negative, so treated as an outpatient</td></tr><tr><td>Referral</td><td>Notification to the public health center (Infectious Diseases Control Law, Article 12)</td><td>At once on diagnosis</td><td>Completed today</td><td>Notified today; the center was told of the suspected case at intake</td></tr><tr><td>Referral</td><td>Contact investigation (household and close contacts)</td><td>Led by the public health center, from diagnosis</td><td>Referred</td><td>The public health center will assess her household and close contacts; their results belong to their own records</td></tr><tr><td>Referral</td><td>Public funding and other help with costs</td><td>At diagnosis</td><td>Completed today</td><td>Public funding application completed with the social worker</td></tr><tr><td>Self-management</td><td>Weight and nutrition</td><td>Every visit; dose review if weight changes by more than about 5 kg</td><td>Completed today</td><td>38.4 kg; dietitian and supplement drinks</td></tr><tr><td>Survey</td><td>Depression screen (PHQ-9)</td><td>At diagnosis, at two months, and at the end of treatment</td><td>Up to date</td><td>PHQ-9 8 at intake, item 9 scored 0</td></tr><tr><td>Referral</td><td>Infectious diseases consultation</td><td>Once at diagnosis, then as advised</td><td>Completed today</td><td>Seen today by Dr. Abernathy-Okoye</td></tr></tbody></table><paragraph>Goal progress:</paragraph><list><item>Complete 182 daily doses within about six and a half months by video-observed therapy. In progress; target 1896-10-20 [S]</item><item>Sputum culture negative at two months. In progress; target 1896-10-20 [S]</item><item>Weight at least 44 kg (BMI about 20) by the end of treatment. In progress; target 1896-10-20 [S]</item><item>Keep writing on a paced schedule without losing income during treatment. In progress; target 1896-10-20 [S]</item><item>No drug-induced liver injury or loss of vision during treatment. In progress; target 1896-10-20 [S]</item></list><paragraph>Guideline basis: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis (2016); Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline (2025); WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-susceptible tuberculosis treatment (2022); Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children (2017); Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis - United States, 2022 (2022); An official ATS statement: hepatotoxicity of antituberculosis therapy (2006); Guidelines for the investigation of contacts of persons with infectious tuberculosis: recommendations from the National Tuberculosis Controllers Association and CDC (2005); 結核 (Tuberculosis): notification criteria under Article 12 of the Infectious Diseases Control Law (current); 結核医療費の公費負担 (Public funding of tuberculosis medical costs under Articles 37 and 37-2 of the Infectious Diseases Control Law) (current); Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition) (2012)</paragraph><paragraph>Follow-up: Two-week review with liver tests, vision and a sputum specimen. Call the same day for hepatitis symptoms or any change in vision. Next scheduled visit 1896-05-01: two-week review on treatment: culture result, liver tests, vision, and release from precautions. [S]</paragraph></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
